Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer clinical trial (NCT06211023). Contact the study team or your healthcare provider for specific answers.

Question 2

How does SHR-A1921 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer clinical trial (NCT06211023). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer clinical trial (NCT06211023). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer clinical trial (NCT06211023). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer clinical trial (NCT06211023). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer clinical trial (NCT06211023). Contact the study team or your healthcare provider for specific answers.

What this study is about